The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D06 | Antibiotics and chemotherapeutics for dermatological use | |
| 3 | D06B | Chemotherapeutics for topical use | |
| 4 | D06BB | Antivirals | |
| 5 | D06BB06 | Penciclovir |
| Active Ingredient | Description | |
|---|---|---|
| Penciclovir |
Penciclovir has demonstrated in vivo and in vitro activity against herpes simplex viruses (types 1 and 2) and varicella zoster virus. Penciclovir triphosphate persists in infected cells for more than 12 hours where it inhibits replication of viral DNA and has a half-life of 9, 10 and 20 hours in cells infected with varicella zoster virus, herpes simplex virus type 1 and herpes simplex virus type 2 respectively. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| VECTAVIR Cream | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
